Home/Filings/4/0001593968-24-000878
4//SEC Filing

MESSEMER DEBORAH M. 4

Accession 0001593968-24-000878

CIK 0001737287other

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 4:31 PM ET

Size

8.3 KB

Accession

0001593968-24-000878

Insider Transaction Report

Form 4
Period: 2024-06-18
Transactions
  • Sale

    Common Stock

    2024-06-18$2.28/sh18,641$42,488166,765 total
Footnotes (2)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/29/2023
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Issuer

Allogene Therapeutics, Inc.

CIK 0001737287

Entity typeother

Related Parties

1
  • filerCIK 0001754424

Filing Metadata

Form type
4
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:31 PM ET
Size
8.3 KB